Dermatology platform PathologyWatch raised $25 million in its Series B financing round, the Salt Lake City-based startup announced today. Crunchbase reported the news.
The company plans to use the money to expand—adding laboratories in Texas, Florida and Arizona—as well as grow its research on skin care diagnostics.
Ceros Capital Markets led the recent funding round while Spark Growth Ventures, Blueprint Health and Blackbrook Management Group participated. Rock Creek Capital and SpringTide, which jointly led the company’s $7 million Series A funding round in July 2020, also invested in its most recent round. Read more.
